BIOA · BioAge Labs Inc. Common Stock
View on chartInsiders & Stakes
| Patrick G. Enright Director | ▲ Buy | Open Market | 1,710,589 Shares held | 9/27/2024 | View profile |
| Cormorant Asset Management, LP | ▲ Buy | Open Market | 1,629,529 Shares held | 9/27/2024 | View profile |
| Pande Vijay Satyanand | ▲ Buy | Open Market | 1,119,195 Shares held | 10/3/2024 | View profile |
| Fortney Kristen Chief Executive Officer | ▼ Sell | Open Market | 976,949 Shares held | 1/13/2026 | View profile |
| Dov A. Goldstein, MD Chief Financial Officer | ▲ Buy | Option Exercise | 36,575 Shares held | 4/23/2026 | View profile |
| James Healy Director | ▲ Buy | Open Market | 26,497 Shares held | 9/27/2024 | View profile |
| Barton Shane Principal Accounting Officer | ▼ Sell | Open Market | 0 Shares held | 6/30/2026 | View profile |
| RUBIN PAUL D Chief Medical Officer | ▼ Sell | Open Market | 0 Shares held | 4/1/2026 | View profile |
Transaction History
| Barton Shane | ▲ Buy | Option Exercise | 7,861 | $34K | 6/30/2026 |
| Barton Shane | ▲ Buy | Option Exercise | 4,290 | $47K | 6/30/2026 |
| Barton Shane | ▲ Buy | Option Exercise | 4,000 | $34K | 6/30/2026 |
| Barton Shane | ▲ Buy | Option Exercise | 4,065 | $17K | 6/30/2026 |
| Barton Shane | ▼ Sell | Open Market | 20,216 | $509K | 6/30/2026 |
| Barton Shane | ▲ Buy | Option Exercise | 8,958 | $39K | 6/29/2026 |
| Barton Shane | ▲ Buy | Option Exercise | 9,301 | $101K | 6/29/2026 |
| Barton Shane | ▲ Buy | Option Exercise | 7,261 | $61K | 6/29/2026 |
| Barton Shane | ▲ Buy | Option Exercise | 14,198 | $62K | 6/29/2026 |
| Barton Shane | ▼ Sell | Open Market | 42,350 | $1.1M | 6/29/2026 |
| Dov A. Goldstein, MD | ▲ Buy | Option Exercise | 3,542 | $16K | 4/23/2026 |
| RUBIN PAUL D | ▲ Buy | Option Exercise | 3,383 | $22K | 4/1/2026 |
| RUBIN PAUL D | ▲ Buy | Option Exercise | 5,437 | $22K | 4/1/2026 |
| RUBIN PAUL D | ▼ Sell | Open Market | 8,820 | $157K | 4/1/2026 |
| RUBIN PAUL D | ▲ Buy | Option Exercise | 5,433 | $22K | 3/2/2026 |
| RUBIN PAUL D | ▲ Buy | Option Exercise | 2,000 | $13K | 3/2/2026 |
| RUBIN PAUL D | ▼ Sell | Open Market | 7,433 | $151K | 3/2/2026 |
| Dov A. Goldstein, MD | ▲ Buy | Option Exercise | 3,542 | $16K | 3/1/2026 |
| RUBIN PAUL D | ▲ Buy | Option Exercise | 2,000 | $13K | 2/2/2026 |
| RUBIN PAUL D | ▲ Buy | Option Exercise | 5,433 | $22K | 2/2/2026 |
| RUBIN PAUL D | ▼ Sell | Open Market | 7,433 | $139K | 2/2/2026 |
| Dov A. Goldstein, MD | ▲ Buy | Option Exercise | 3,541 | $16K | 2/1/2026 |
| Dov A. Goldstein, MD | ▲ Buy | Option Exercise | 3,542 | $16K | 1/16/2026 |
| Dov A. Goldstein, MD | ▼ Sell | Open Market | 8,974 | $165K | 1/13/2026 |
| Dov A. Goldstein, MD | ▼ Sell | Open Market | 4,440 | $86K | 1/13/2026 |
| Dov A. Goldstein, MD | ▼ Sell | Open Market | 11,663 | $240K | 1/13/2026 |
| Dov A. Goldstein, MD | ▼ Sell | Open Market | 1,923 | $41K | 1/13/2026 |
| Fortney Kristen | ▼ Sell | Open Market | 233,107 | $4.2M | 1/13/2026 |
| Dov A. Goldstein, MD | ▲ Buy | Option Exercise | 27,000 | $227K | 1/13/2026 |
| RUBIN PAUL D | ▼ Sell | Open Market | 7,433 | $95K | 1/2/2026 |
| RUBIN PAUL D | ▲ Buy | Option Exercise | 5,433 | $22K | 1/2/2026 |
| RUBIN PAUL D | ▲ Buy | Option Exercise | 2,000 | $13K | 1/2/2026 |
| RUBIN PAUL D | ▼ Sell | Open Market | 18,000 | $216K | 12/9/2025 |
| RUBIN PAUL D | ▲ Buy | Option Exercise | 18,000 | $118K | 12/9/2025 |
| RUBIN PAUL D | ▲ Buy | Option Exercise | 68,897 | $283K | 12/4/2025 |
| RUBIN PAUL D | ▼ Sell | Open Market | 68,897 | $702K | 12/4/2025 |
| Pande Vijay Satyanand | ▲ Buy | Open Market | 25,306 | $504K | 10/3/2024 |
| Pande Vijay Satyanand | ▲ Buy | Open Market | 67,096 | $1.3M | 10/2/2024 |
| Pande Vijay Satyanand | ▲ Buy | Open Market | 126,793 | $2.5M | 10/1/2024 |
| Barton Shane | ▲ Buy | Open Market | 2,632 | $47K | 9/27/2024 |
| Patrick G. Enright | ▼ Sell | Other | 1,310,589 | — | 9/27/2024 |
| Cormorant Asset Management, LP | ▲ Buy | Open Market | 450,000 | $8.1M | 9/27/2024 |
| Pande Vijay Satyanand | ▼ Sell | Other | 855,972 | — | 9/27/2024 |
| Pande Vijay Satyanand | ▼ Sell | Other | 413,100 | — | 9/27/2024 |
| Pande Vijay Satyanand | ▼ Sell | Other | 189,609 | — | 9/27/2024 |
| Pande Vijay Satyanand | ▼ Sell | Other | 655,294 | — | 9/27/2024 |
| Pande Vijay Satyanand | ▲ Buy | Open Market | 900,000 | $16.2M | 9/27/2024 |
| Patrick G. Enright | ▲ Buy | Open Market | 400,000 | $7.2M | 9/27/2024 |
| James Healy | ▼ Sell | Other | 1,638,236 | — | 9/27/2024 |
| James Healy | ▲ Buy | Open Market | 588,888 | $10.6M | 9/27/2024 |
| James Healy | ▲ Buy | Open Market | 26,497 | $477K | 9/27/2024 |
| Cormorant Asset Management, LP | ▼ Sell | Other | 1,179,529 | — | 9/27/2024 |
| James Healy | ▲ Buy | Open Market | 18,353 | $330K | 9/27/2024 |
| James Healy | ▲ Buy | Open Market | 21,814 | $393K | 9/27/2024 |
| James Healy | ▲ Buy | Open Market | 11,113 | $200K | 9/27/2024 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
BioAge Labs to Present at Investor Conferences
BioAge Labs announced it will present at upcoming investor conferences, providing a platform to share company updates with the market. The stock is currently trading near its 52-week low, which may increase attention from investors seeking value. This corporate activity adds context to the recent whale alerts noted in healthcare stocks.
BioAge Labs to Present at Investor Conferences. BioAge Labs announced it will present at upcoming investor conferences, providing a platform to share company updates with the market. The stock is currently trading near its 52-week low, which may increase attention from investors seeking value. This corporate activity adds context to the recent whale alerts noted in healthcare stocks.